{"name":"Taiwan Mitochondrion Applied Technology Co., Ltd.","slug":"taiwan-mitochondrion-applied-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Aadipose-Derived Mesenchymal Stem Cells","genericName":"Aadipose-Derived Mesenchymal Stem Cells","slug":"aadipose-derived-mesenchymal-stem-cells","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Aadipose-Derived Mesenchymal Stem Cells","genericName":"Aadipose-Derived Mesenchymal Stem Cells","slug":"aadipose-derived-mesenchymal-stem-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxORV9rNzJNLWJ2WWxXTktiM05GaUE3a3k2Z3dub2hlREZWUGdvVDBNT05Xbmh2U1lUWmFfMzFHaHhJY1Rhb2FmNWx6M3hwNW54YXQxeEZ3UFE1U1AyNy1JUVM4TTVLYVdEdGpkenJpaUZ1a2tyLUh6LWhMRGJjZVF5LUtVWmRPVTBVaXNKNXpTU2dNck5OaE1raVRYd1dwUXh4alRsemtURkZJc0VlUE1SdmpSYVpsZE16eXFuV3llaURzSVJ3MUtRYy1yYWFEaFJKZG42YndSbmhOV0U?oc=5","date":"2025-04-22","type":"pipeline","source":"prnewswire.com","summary":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight - prnewswire.com","headline":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNbjJpMUlyUXpZeHFYNUlhNDJBbWp4TXdxN3ZwZ1E5UHh6Q3lVWUhIa01QOU10VWFHWXhwTUpWZ19EV1Z3QW9EakJOUVpuUUFmREdHQnVWS3ZRN2I4WF9HVDZfODloVTg4ZTMwWG9wMUNnbEU1N1haNkJOQXRpUV9lWWVmdk1fYlpCbTlTUUtxczBObTNibWotTm9iRUFTOGpIbFpDM3BwbklBRExmUHB2d1Bialpaa1lNa1N2WnJmNzltTVFSVldfem1la3VXMG5YbkRPMlBBMVdnOHZ6MzVwWWhhWHByZ29UZ25hUnVBLWdYMWZ2OXZMVDlaZXdBdl8tSVBB?oc=5","date":"2025-02-17","type":"pipeline","source":"prnewswire.com","summary":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight - prnewswire.com","headline":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQdzNUZFRCTVhoSUllbW1XakkxWEZseVhpUVpUMldwNkhMSGZSR0EtYlFZdTREMG5hVUpPWDRwMEJfNW94eU1JbzdXeUVubkl5MnZtUFZLWTMzME9kbW9yTnFkVWdtQjJLRjVBdWtxeHMyTDh6Rk5peXNDaHUxSWthampFTVdfbVowNExVUmFvMnpOYjlsVGs1MmpLbHlvbW56RmlBOE5zVnZzY2VVYnlrU2dST0k5RmVGTU9GdVI5eDBDd1lURE1vU2tBV1ZuR1lwUzNwanBWS29uNW5qZVVaVGtvT1VkdXVkU2swQlQxQVgtNWVkdk95UEVJUVRycDAzNk9mSjl0b1RZaXV1cGxzSlg1bUE3Q3FTWmVLVFgzWW9YQ2M5amNaeQ?oc=5","date":"2025-02-13","type":"trial","source":"GlobeNewswire","summary":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel - GlobeNewswire","headline":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNR3JCQnhRWFJKakk0Ykwxd25Za2xkR2lvY1ZPbGNUR29BaDZiaHZ5TWRZbmxUUm9RaXNPWFNjaFduVUw5NHBZRmZWQ01KYnUwNlVlRzg3UFVZcWJ4eFpzNHk1VGZLNDd4OWwzUllQRkIyZFNsVzB5UDBNd3Q3OGFMQllCR2NDczdtaXhETmhhM0swQ2oxT1NRRnlvdkRQbzRGLWFJX3BqTXRXcHQya3ctdFJEYlc0YlAwdFo0bW1TMFNTQUhSb01scmI2SFYwN3RISDhRUU9yazBLWklLMU9nbEJINGdaa3QtdTh3d0dYdHVnY3R1b2FEZDFWcGk2YkdqX25yOVVNUC1xOVRVWDVKcl80NGgwc0ZwZW9MLUJLYjFmWkl6T1NOT1hXQ1h4eVlNNTVLVU9pWDB4bFBLVUdiSEMzT0wyZ0ZVMERyTmdYanlXWGhwbGc?oc=5","date":"2024-11-13","type":"trial","source":"GlobeNewswire","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQaHVqSXFvY2lvRTMxZWFmU293SFBoVGpOeXZQSmxkT0NScTZWc3VTUmcwS3FKajRYS1o5UjZoSGRjZEVSNjhUYjF5a0o1N2ZQcDhSV25ZVUhEQ1dzdDR5VmhOaFl2TjNfOG1nNEZFQ0R0SzJuTzRrZU5YckExYUVnNWwwNnpQNXlqSC1zMDFORXE4Vk5mOHBsbnhEQVgxVVY1bkw5WC14aWdnU04zaWx6MVBHbUk3TWJ5bzV5eHdvSVR5SkRqaVR2c29MTDlnT2pPbi1yMDZ2aWlRTDdwWVpV?oc=5","date":"2024-10-30","type":"pipeline","source":"prnewswire.com","summary":"Global Neurological Biomarkers Market to Surpass USD 16 Billion Mark by 2030 | DelveInsight - prnewswire.com","headline":"Global Neurological Biomarkers Market to Surpass USD 16 Billion Mark by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gJBVV95cUxQUGx5Nnc2U2laS20yUFdZSFh3ekpCN2Y2aUI0M1pPajZnYVlySy1RTktGRzBEUmlGay04c0hWUDN0Tm9WWGF4dVMxdlpEX2FMLWhVSHd3N1c4bWxuMkRyck91Z1hSeVBmS2pkQ0U2dnpDb2VXVF9yNERJUTBIZEFBY2tyNUpVWm5wdmNVQUdqbzc1S0pNUmlRQ2tKWFNuTjJyUWtVblRpaEtSV3lIWE1ZSFZSaFRWMi05NEk3VE9MLUZ4U2VkSDN4UTlwQkZxeXJsZnVIM0ZxWjh4STZfM2puRDhGZTI1Rmg5YlFrVHk1WnZxaGVldjNpTDJKZUxsRVEyX1FFeVVnQXdveTJ1RHdBalBxcTN0LUYyelhINXhHLWtaMG4wSnFBSnd4Q0dJbTJsckVvN2NCbEw4VG1lSndldTlEajZDOTZTb2hBQm1ybGxMU1pwSmI1RWkxd192aldTNGc?oc=5","date":"2024-10-09","type":"trial","source":"prnewswire.com","summary":"Cell and Gene Therapy in Parkinson's Disease Clinical Trial Pipeline Analysis Demonstrates 18+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - prnews","headline":"Cell and Gene Therapy in Parkinson's Disease Clinical Trial Pipeline Analysis Demonstrates 18+ Key Companies at the Hori","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNeDdqQ05ZcVhNR3FNSGg0TnR6UHJhckRJTnhPbmdkV0xUZWhiRjdmZUREdnlhbjRsZTJVaEdwUHVBMmp5N3lMckZqVVd2ZkxWX3pYOUpqdTUwUGlFRGxpcndPd1JpeTZ1dUJEbm16RlRMTmNCdk5jODFCNG1QOFRzNi1vVm9oMUhoVFJlSkc3UlI1cVdsMWxxdzBGeTFxN2F1eVVJbURHQU04SEdRSzVsS3k1UFVLc2dmQzJyRko4RlVrNW9jTTVBeXhObWhFUTRJTEtKTy1wQVJvTGpvVklqNm5jQU9qdkNSbWJKc0FHdFZlcXMtdHotdUt6ZG9hcEluWEN6YWx5cFg4bTh2TkdJRFhMWjBTMkc0c1pNX2l1Y1daU3BicnJLRWtBdjA?oc=5","date":"2023-04-19","type":"trial","source":"prnewswire.com","summary":"Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Working in the Domain | DelveInsight - prnewswire.com","headline":"Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Workin","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}